FDA Inspection
Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.FDA Inspection 1325140 - Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. - June 16, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Luoxin Aurovitas Pharma (Chengdu) Co., Ltd., with an inspection on June 16, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- June 16, 2026
- Product Type
- Human Drugs
Open in Dashboard
ID · ccee6efc-4f3d-4190-9b5f-5ef838e8f18d